GCP
RPRX icon

GSA Capital Partners’s Royalty Pharma RPRX Stock Holding History

GSA Capital Partners’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,454
Closed -$214K – 2117
2026
Q1 		$214K Sell
4,454
-10,463
-70% -$458K 0.01% 1425
2025
Q4 		$576K Buy
14,917
+1,931
+15% +$73.6K 0.05% 717
2025
Q3 		$458K Buy
+12,986
New +$470K 0.04% 906
2025
Q1 		– Sell
-61,819
Closed -$1.58M – 2015
2024
Q4 		$1.58M Buy
61,819
+17,284
+39% +$458K 0.12% 163
2024
Q3 		$1.26M Sell
44,535
-3,472
-7% -$96.2K 0.1% 328
2024
Q2 		$1.27M Buy
48,007
+39,966
+497% +$1.11M 0.09% 357
2024
Q1 		$244K Sell
8,041
-6,196
-44% -$183K 0.02% 1318
2023
Q4 		$400K Sell
14,237
-56,554
-80% -$1.55M 0.03% 944
2023
Q3 		$1.92M Buy
70,791
+58,012
+454% +$1.72M 0.16% 118
2023
Q2 		$393K Sell
12,779
-290
-2% -$9.82K 0.04% 889
2023
Q1 		$471K Buy
+13,069
New +$485K 0.05% 753
2022
Q3 		– Sell
-12,874
Closed -$541K – 1815
2022
Q2 		$541K Buy
+12,874
New +$528K 0.08% 449
2022
Q1 		– Sell
-7,857
Closed -$313K – 1781
2021
Q4 		$313K Buy
+7,857
New +$305K 0.04% 902
2021
Q3 		– Sell
-7,440
Closed -$305K – 1720
2021
Q2 		$305K Buy
+7,440
New +$316K 0.03% 937
2021
Q1 		– Sell
-4,700
Closed -$235K – 1433
2020
Q4 		$235K Buy
+4,700
New +$199K 0.04% 893

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GSA Capital Partners's RPRX Position: Q2 2026 in Review

GSA Capital Partners sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 4,454 shares — an estimated $214K sold.

GSA Capital Partners first reported a position in RPRX in Q4 2020 and held it in 15 quarters. The position peaked at $1.92M in Q3 2023. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • GSA Capital Partners reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 4,454 Royalty Pharma shares in Q2 2026, an estimated $214K.
  • GSA Capital Partners first reported a position in Royalty Pharma in Q4 2020 and held it in 15 quarters.
  • GSA Capital Partners's Royalty Pharma position peaked at $1.92M in Q3 2023.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.